The 1st most cited open-access journal in Pharmacology & Pharmacy
Experimental Pharmacology and Drug Discovery publishes research on mechanisms of drug action at the molecular, cellular and organism level by analyzing the interaction with receptors and/or other specific biological targets, including enzymes, ion channels, transporters, and transcription factors.
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
Experimental Pharmacology and Drug Discovery welcomes submissions of the following article types: Book Review, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Research Snapshot, Review, Specialty Grand Challenge and Technology Report.
All manuscripts must be submitted directly to the section Experimental Pharmacology and Drug Discovery, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Experimental Pharmacology and Drug Discovery will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.